398 related articles for article (PubMed ID: 38203562)
1. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review.
Ornoy A; Echefu B; Becker M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203562
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
3. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
[TBL] [Abstract][Full Text] [Related]
4. Teratogenicity of sodium valproate.
Alsdorf R; Wyszynski DF
Expert Opin Drug Saf; 2005 Mar; 4(2):345-53. PubMed ID: 15794725
[TBL] [Abstract][Full Text] [Related]
5. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.
Wegner C; Nau H
Neurology; 1992 Apr; 42(4 Suppl 5):17-24. PubMed ID: 1574172
[TBL] [Abstract][Full Text] [Related]
6. Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.
Kini U; Lee R; Jones A; Smith S; Ramsden S; Fryer A; Clayton-Smith J;
Eur J Med Genet; 2007; 50(6):411-20. PubMed ID: 17951123
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
Nau H; Hauck RS; Ehlers K
Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
[TBL] [Abstract][Full Text] [Related]
8. Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes.
Pennati R; Groppelli S; de Bernardi F; Sotgia C
Teratog Carcinog Mutagen; 2001; 21(2):121-33. PubMed ID: 11223890
[TBL] [Abstract][Full Text] [Related]
9. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of teratogenesis: folic acid and antiepileptic therapy.
Dansky LV; Rosenblatt DS; Andermann E
Neurology; 1992 Apr; 42(4 Suppl 5):32-42. PubMed ID: 1574174
[TBL] [Abstract][Full Text] [Related]
11. Prenatal valproate exposure and adverse neurodevelopmental outcomes: Does sex matter?
Honybun E; Thwaites R; Malpas CB; Rayner G; Anderson A; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE; Perucca P
Epilepsia; 2021 Mar; 62(3):709-719. PubMed ID: 33547648
[TBL] [Abstract][Full Text] [Related]
12. Management issues for women with epilepsy: neural tube defects and folic acid supplementation.
Yerby MS
Neurology; 2003 Sep; 61(6 Suppl 2):S23-6. PubMed ID: 14504306
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
[TBL] [Abstract][Full Text] [Related]
14.
Ornoy A; Becker M; Weinstein-Fudim L; Ergaz Z
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466248
[No Abstract] [Full Text] [Related]
15. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
Löscher W; Nau H; Marescaux C; Vergnes M
Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
[TBL] [Abstract][Full Text] [Related]
16. Brief report novel mechanism for valproate-induced teratogenicity.
Fathe K; Palacios A; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2014 Aug; 100(8):592-7. PubMed ID: 25066307
[TBL] [Abstract][Full Text] [Related]
17. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
Elmazar MM; Thiel R; Nau H
Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
[TBL] [Abstract][Full Text] [Related]
18. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy.
Ornoy A
Reprod Toxicol; 2006 Aug; 22(2):214-26. PubMed ID: 16621443
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on neural tube defects with special reference to Valproic Acid.
Verrotti A; Tana M; Pelliccia P; Chiarelli F; Latini G
Endocr Metab Immune Disord Drug Targets; 2006 Mar; 6(1):25-31. PubMed ID: 16611162
[TBL] [Abstract][Full Text] [Related]
20. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.
Jäger-Roman E; Deichl A; Jakob S; Hartmann AM; Koch S; Rating D; Steldinger R; Nau H; Helge H
J Pediatr; 1986 Jun; 108(6):997-1004. PubMed ID: 3086531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
